Viewing Study NCT01374503

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-24 @ 7:49 PM

Ignite Modification Date: 2026-03-05 @ 8:13 PM

Study NCT ID: NCT01374503

Status: TERMINATED

Last Update Posted: 2012-04-17

First Post: 2011-06-14

Is NOT Gene Therapy: True

Has Adverse Events: False

Brief Title: First in Man Study of ALX-0651, a Nanobody Inhibiting CXCR4

Sponsor: Ablynx, a Sanofi company

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module